Celcuity Inc. — Investor Relations & Filings
Filings indexed
484
across all filing types
Latest filing
2026-03-26
Annual Report
Country
US
United States of America
Listing
US
CELC
Celcuity Inc. is a clinical-stage biotechnology company focused on developing targeted therapies for multiple solid tumor indications. The company's approach centers on the PI3K/AKT/mTOR (PAM) pathway, a critical signaling cascade involved in cancer cell growth and survival. Its lead product candidate, gedatolisib, is a potential first-in-class, pan-PI3K and mTORC1/2 inhibitor designed to comprehensively blockade the PAM pathway. Celcuity's pipeline is advancing treatments with a focus on breast and prostate cancers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-K - Celcuity Inc. (0001603454) (Filer) | 2026-03-26 | English | |
| SCHEDULE 13D/A - Celcuity Inc. (0001603454) (Subject) | 2026-03-24 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| 4 - CELCUITY INC. (0001603454) (Filer) | 2026-02-13 | English | |
| 8-K Filing | 2026-02-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 33047727 | 10-K - Celcuity Inc. (0001603454) (Filer) | 2026-03-26 | English | ||
| 33034993 | SCHEDULE 13D/A - Celcuity Inc. (0001603454) (Subject) | 2026-03-24 | English | ||
| 30852708 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 30852692 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32894939 | 4 - CELCUITY INC. (0001603454) (Filer) | 2026-02-13 | English | ||
| 30852638 | 8-K Filing | 2026-02-12 | English | ||
| 30852627 | SCHEDULE 13G/A Filing | 2026-02-12 | English | ||
| 30852667 | 4 Filing | 2026-01-29 | English | ||
| 30852633 | SCHEDULE 13D/A Filing | 2026-01-16 | English | ||
| 12761760 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12761759 | S-3ASR | 2026-01-09 | English | ||
|
2025
4 filings
| |||||
| 12761761 | Director's Dealing 2025 | 2025-12-09 | English | ||
| 12761762 | Director's Dealing 2025 | 2025-12-08 | English | ||
| 12761763 | Regulatory Filings 2025 | 2025-12-05 | English | ||
| 12761764 | Director's Dealing 2025 | 2025-12-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cell Bio Human Tech Co., Ltd
Develops and manufactures cellulose-based nonwoven fabrics …
|
318160 | KR | Professional, scientific and te… |
|
CEL SCI CORP
Clinical-stage biotech developing immunotherapies for cance…
|
CVM | US | Professional, scientific and te… |
|
Celyad Oncology SA
Biotechnology company developing innovative CAR-T cell ther…
|
CYAD | BE | Professional, scientific and te… |
|
Ceres Power Holdings PLC
A developer of solid oxide technology for clean power and g…
|
CWR | GB | Professional, scientific and te… |
|
Certara, Inc.
Accelerates drug development using biosimulation software, …
|
CERT | US | Professional, scientific and te… |
|
CervoMed Inc.
A clinical-stage biotech developing treatments for age-rela…
|
CRVO | US | Professional, scientific and te… |
|
Chabiotech Co.,Ltd.
Develops cell/gene therapies and provides CDMO and bio-bank…
|
085660 | KR | Professional, scientific and te… |
|
CHAMPIONS ONCOLOGY, INC.
A CRO providing end-to-end solutions to accelerate oncology…
|
CSBR | US | Professional, scientific and te… |
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
A contract research organization supporting drug discovery …
|
CRL | US | Professional, scientific and te… |
|
ChemPartner PharmaTech Co., Ltd.
Global CRO and CDMO providing integrated drug discovery and…
|
300149 | CN | Professional, scientific and te… |
Celcuity Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31605/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31605 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31605 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31605 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31605}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Celcuity Inc. (id: 31605)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.